MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Cash Flow Overview

Change in Cash
-$331K
Free Cash flow
-$17,558K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Proceeds from maturities of mark...
    • Interest income
    • Stock-based compensation
    • Others
Negative Cash Flow Breakdown
    • Purchases of marketable securiti...
    • Accretion of marketable securiti...
    • Accrued expenses
    • Others

Cash Flow
2025-09-30
2025-06-30
Total operating expenses
84,304 NaN
Loss from operations
-84,304 NaN
Interest income
7,088 NaN
Other expense
-40 NaN
Total other (income) expense
7,048 NaN
Net loss
-22,829 -54,427
Depreciation
58 161
Amortization of right-of-use assets - operating
268 518
Stock-based compensation
4,601 9,606
Accretion of marketable securities, net
-1,063 -2,907
Prepaid expenses and other assets
-1,943 -1,988
Operating lease liabilities
-270 -500
Accounts payable
101 -2,236
Accrued expenses
-317 802
Net cash used in operating activities
-17,508 -46,995
Purchases of marketable securities, available-for-sale
34,774 53,348
Proceeds from maturities of marketable securities, available-for-sale
51,875 105,013
Purchases of property and equipment
50 58
Net cash provided by (used in) investing activities
17,051 51,607
Proceeds from exercise of stock options
203 NaN
Proceeds from issuance of common stock under employee stock purchase plan
0 68
Net cash provided by financing activities
203 68
Effect of exchange rates on cash, cash equivalents and restricted cash
-77 361
Net increase in cash, cash equivalents and restricted cash
-331 5,041
Cash and cash equivalents at beginning of period
28,235 NaN
Cash and cash equivalents at end of period
32,945 NaN
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from maturitiesof marketable...$51,875K Proceeds from exercise ofstock options$203K Net cash provided by(used in) investing...$17,051K Net cash provided byfinancing activities$203K Canceled cashflow$34,824K Net increase incash, cash...-$331K Canceled cashflow$17,254K Stock-based compensation$4,601K Prepaid expenses andother assets-$1,943K Amortization of right-of-useassets - operating$268K Accounts payable$101K Depreciation$58K Interest income$7,088K Purchases of marketablesecurities,...$34,774K Purchases of property andequipment$50K Net cash used inoperating activities-$17,508K Canceled cashflow$6,971K Effect of exchangerates on cash, cash...-$77K something is missing$54,427K Total other (income)expense$7,048K Canceled cashflow$40K Net loss-$22,829K Canceled cashflow$61,475K Accretion of marketablesecurities, net-$1,063K Accrued expenses-$317K Operating leaseliabilities-$270K Other expense-$40K Loss from operations-$84,304K Total operatingexpenses$84,304K

Ventyx Biosciences, Inc. (VTYX)

Ventyx Biosciences, Inc. (VTYX)